A study finds treatment with anti-CGRP mAbs does not significantly affect blood pressure or increase the occurrence of hypertension (compared to general population trends) in people 60+. In this Migraine Minute, Molly O’Brien explains the findings.
Read More: bit.ly/3zpcYSB
#migraine #migrainemanagement #migrainesupport #headache #chronicmigraine #chronicillness
コメント